Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hanover Insurance (THG) Cash & Equivalents (2016 - 2025)

Hanover Insurance's Cash & Equivalents history spans 17 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 157.8% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 157.8%, while the annual FY2025 figure was $1.1 billion, 157.8% up from the prior year.
  • Cash & Equivalents reached $1.1 billion in Q4 2025 per THG's latest filing, up from $915.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q4 2025 to a low of $106.4 million in Q2 2021.
  • Average Cash & Equivalents over 5 years is $326.5 million, with a median of $268.3 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: plummeted 41.73% in 2021, then surged 157.8% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $230.9 million in 2021, then soared by 32.09% to $305.0 million in 2022, then increased by 3.64% to $316.1 million in 2023, then soared by 37.77% to $435.5 million in 2024, then soared by 157.8% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for THG's Cash & Equivalents are $1.1 billion (Q4 2025), $915.7 million (Q3 2025), and $244.1 million (Q2 2025).